Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05831540 · ClinicalTrials.gov registry record · NA
Clinical Decision Support Tools to Increase Human Papillomavirus (HPV) Vaccination in Adolescents in Pharmacies
A NA study, sponsored by Fred Hutchinson Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT05831540 is a NA study that was terminated before completion, run by Fred Hutchinson Cancer Center. The registered enrollment target is 31 participants.
The verdict
NCT05831540, a NA study, was terminated before completion, sponsored by Fred Hutchinson Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
This clinical trial develops and tests how well a clinical decision support (CDS) tool works to increase human papillomavirus (HPV) vaccination of children between the age of 9-17 (adolescents) in pharmacies. HPV vaccination rate in eligible adolescents remains low even though over 90% of the cancers in adults caused by HPV can be prevented by the HPV vaccine. The National Vaccine Advisory Committee recommends HPV vaccinations to be given in pharmacies to increase access to vaccines, but pharmacy processes and lack of awareness of the service among parents impact the use of local pharmacies for HPV vaccinations. Using a focus group may be an effective method to develop a CDS tool and create a process that may be more convenient for parents to get their adolescent's vaccine at their local pharmacy. A CDS tool may make it easier to obtain HPV vaccines, and as a result increase the adolescent HPV vaccination rate and reduce the incidence of cancer caused by HPV.
Interventions
- OTHER Survey Administration
- OTHER Discussion
- OTHER Educational Activity
- BEHAVIORAL Healthcare Activity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2024-02-28 |
| Est. Completion | 2024-11-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05831540
The ClinicalTrials.gov registry entry for NCT05831540 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Survey Administration is the first listed.
NCT05831540 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05831540 about?
NCT05831540 is a clinical study titled "Clinical Decision Support Tools to Increase Human Papillomavirus (HPV) Vaccination in Adolescents in Pharmacies". This clinical trial develops and tests how well a clinical decision support (CDS) tool works to increase human papillomavirus (HPV) vaccination of children between the age of 9-17 (adolescents) in pharmacies. HPV vaccination rate in eligible adolescents remains low even though over 90% of the cancer...
What is the current status of trial NCT05831540?
This trial is currently terminated. It is a NA study. The enrollment target is 31 participants. The study started on 2024-02-28. Estimated completion is 2024-11-22.
What interventions are being tested in trial NCT05831540?
The interventions under investigation include: Survey Administration (OTHER), Discussion (OTHER), Educational Activity (OTHER), Healthcare Activity (BEHAVIORAL).
Who is sponsoring clinical trial NCT05831540?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.